Ghrelin (rat), Endogenous GHS agonist (ab120231)
Key features and details
- Endogenous GHS agonist
- CAS Number: 258338-12-4
- Soluble in water
- Form / State: Solid
- Source: Synthetic
Overview
-
Product name
Ghrelin (rat), Endogenous GHS agonist -
Description
Endogenous GHS agonist -
Biological description
Endogenous agonist peptide for the ghrelin (GHS) receptor. Stimulates release of growth hormone from the pituitary gland and regulates feeding, growth and energy production.
-
CAS Number
258338-12-4 -
Chemical structure
Properties
-
Molecular weight
3314.83 -
Molecular formula
C147H245N45O42 -
Sequence
GSSFLSPEHQKAQQRKESKKPPAKLQPR (Modifications: Ser-2 = Cys(n-oct)) -
PubChem identifier
90479797 -
Storage instructions
Store at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months. -
Solubility overview
Soluble in water -
Handling
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one week. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
-
Source
Synthetic
-
Research areas
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab120231 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
Functional Studies |
Use at an assay dependent concentration.
|
Notes |
---|
Functional Studies
Use at an assay dependent concentration. |
Images
-
2D chemical structure image of ab120231, Ghrelin (rat), Endogenous GHS agonist
-
ab6427 staining dopamine in PC12 cells treated with ghrelin (rat) (ab120231), by ICC/IF. Decrease in dopamine expression correlates with increased concentration of ghrelin, as described in literature.
The cells were incubated at 37°C for 10 minutes in media containing different concentrations of ab120231 (ghrelin) in DMSO, fixed with 100% methanol for 5 minutes at -20°C and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab6427 (1/200 dilution) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 goat anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
References (4)
ab120231 has been referenced in 4 publications.
- Yu Y et al. Ghrelin attenuates infectious bursal disease virus-induced early inflammatory response and bursal injury in chicken. Poult Sci 99:5399-5406 (2020). PubMed: 33142456
- Miao H et al. Ghrelin Promotes Proliferation and Inhibits Differentiation of 3T3-L1 and Human Primary Preadipocytes. Front Physiol 10:1296 (2019). PubMed: 31681009
- Li C et al. Defined Paraventricular Hypothalamic Populations Exhibit Differential Responses to Food Contingent on Caloric State. Cell Metab 29:681-694.e5 (2019). PubMed: 30472090
- Alhashem F et al. Exercise protects against obesity induced semen abnormalities via downregulating stem cell factor, upregulating Ghrelin and normalizing oxidative stress. EXCLI J 13:551-72 (2014). PubMed: 26417283